Urawa, Japan

Totaro Yamaguchi

This inventor holds 12 USPTO granted patents. Top assignee: Tanabe Seiyaku Company, Limited. Active years: 1977-1993.


% Patents Active = 100.0

Average Co-Inventor Count = 4.4

ph-index = 5

Forward Citations = 54(Granted Patents)


Location History:

  • Yono, JA (1977)
  • Yono, JP (1982)
  • Urawa, JP (1985 - 1993)

Company Filing History:


Years Active: 1977-1993

Loading Chart...
12 patents (USPTO):Explore Patents

Title: The Innovations of Totaro Yamaguchi

Introduction

Totaro Yamaguchi is a prominent inventor based in Urawa, Japan. He has made significant contributions to the field of chemistry, particularly in the development of antimicrobial compounds. With a total of 12 patents to his name, Yamaguchi's work has had a considerable impact on pharmaceutical research and development.

Latest Patents

Yamaguchi's latest patents include a mercaptan compound characterized by a specific formula, wherein R³ can be a hydrogen atom or a lower alkyl group, or a salt thereof. Another notable patent is for 1-Methylcarbapenem derivatives, which are defined by a formula where R¹ is a hydrogen atom or a hydroxy-protecting group, R² is a hydrogen atom or an ester residue, and R³ is a hydrogen atom or a lower alkyl group. These derivatives exhibit excellent antimicrobial activities and are valuable as antimicrobial drugs.

Career Highlights

Throughout his career, Yamaguchi has worked with reputable companies such as Tanabe Seiyaku Company, Limited and Tanabe Seikaku Co., Ltd. His experience in these organizations has allowed him to refine his skills and contribute to significant advancements in medicinal chemistry.

Collaborations

Yamaguchi has collaborated with notable colleagues, including Satoshi Ohshima and Toyonari Oine. These partnerships have fostered innovation and have been instrumental in the development of his patented compounds.

Conclusion

Totaro Yamaguchi's contributions to the field of chemistry and his innovative patents highlight his role as a key figure in pharmaceutical research. His work continues to influence the development of new antimicrobial drugs, showcasing the importance of innovation in science.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…